Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopia

Orasis Advances Presbyopia Candidate to Phase 3 Clinical Trials HERZLIYA, Israel, September 10, 2020 - Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing an innovative pharmaceutical solution for…

Continue ReadingOrasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopia